[Pediatric COVID-19 - Pathophysiology, immune responses, genetic predispositions, hyperinflammatory syndrome]

Géraldine Blanchard-Rohner1, Jana Pachlopnik Schmid2, Fabio Candotti3

  • 1Unité d'immunologie-vaccinologie pédiatrique, Service de pédiatrie générale, Département de la femme, de l'enfant et de l'adolescent, HUG, 1211 Genève 14.

Revue Medicale Suisse
|February 18, 2021
PubMed

Insights

Children initially seemed spared from SARS-CoV-2, but multisystem inflammatory syndrome in children (MIS-C) emerged. This syndrome suggests an immune overreaction, with its mechanisms and risk factors still under investigation.

Area of Science:

  • Pediatric immunology
  • Infectious diseases
  • Viral pathogenesis

Background:

  • The SARS-CoV-2 pandemic initially appeared to spare children from severe illness.
  • However, a novel inflammatory condition, multisystem inflammatory syndrome in children (MIS-C), emerged in spring 2020.
  • The characteristics of MIS-C suggest an immunologic response rather than direct viral damage.

Purpose of the Study:

  • To review current knowledge on the immune response to SARS-CoV-2 in pediatric populations.
  • To summarize the understanding of multisystem inflammatory syndrome in children (MIS-C).
  • To explore potential immunologic mechanisms and risk factors for MIS-C.

Main Methods:

  • Literature review of studies on SARS-CoV-2 infection in children.
  • Analysis of clinical data and immunological findings related to MIS-C.
  • Synthesis of existing research on pediatric inflammatory responses to viral infections.

Main Results:

  • Children mount distinct immune responses to SARS-CoV-2 compared to adults.
  • MIS-C presents with significant inflammation affecting multiple organ systems.
  • The interval between SARS-CoV-2 infection and MIS-C onset points to a post-infectious immune dysregulation.

Conclusions:

  • MIS-C is a serious post-infectious complication in children, likely driven by immune system dysregulation.
  • Further research is needed to fully elucidate the pathophysiology and identify risk factors for MIS-C.
  • Understanding the pediatric immune response to SARS-CoV-2 is crucial for managing MIS-C.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
960
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
543
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K